These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 8413047)
21. Comparison of the effects of diclofenac or other non-steroidal anti-inflammatory drugs (NSAIDs) and diclofenac or other NSAIDs in combination with proton pump inhibitors (PPI) on hospitalisation due to peptic ulcer disease. Höer A; Gothe H; Schiffhorst G; Sterzel A; Grass U; Häussler B Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):854-8. PubMed ID: 17323403 [TBL] [Abstract][Full Text] [Related]
22. Risk factors of peptic ulcer in 4943 inpatients. Talamini G; Tommasi M; Amadei V; Pajusco B; Fratucello A; Lechi A; Scroccaro G; Vantini I J Clin Gastroenterol; 2008 Apr; 42(4):373-80. PubMed ID: 18277902 [TBL] [Abstract][Full Text] [Related]
23. A survey of peptic ulcers associated with NSAIDs. Gleeson MH Eur J Rheumatol Inflamm; 1982; 5(3):308-12. PubMed ID: 7084293 [TBL] [Abstract][Full Text] [Related]
24. The effectiveness of (IgG-ELISA) serology as an alternative diagnostic method for detecting Helicobacter pylori infection in patients with gastro-intestinal bleeding due to gastro-duodenal ulcer. García-Díaz E; Castro-Fernández M; Romero-Gómez M; Vargas-Romero J Rev Esp Enferm Dig; 2002 Dec; 94(12):725-36. PubMed ID: 12733331 [TBL] [Abstract][Full Text] [Related]
26. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe. Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261 [TBL] [Abstract][Full Text] [Related]
27. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications. Goldstein JL; Howard KB; Walton SM; McLaughlin TP; Kruzikas DT Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1337-45. PubMed ID: 17088110 [TBL] [Abstract][Full Text] [Related]
28. Upper gastrointestinal disorders induced by non-steroidal anti-inflammatory drugs. Chiba T; Sato K; Kudara N; Shinozaki H; Ikeda K; Sato K; Endo M; Orii S; Suzuki K Inflammopharmacology; 2008 Feb; 16(1):16-20. PubMed ID: 18256801 [TBL] [Abstract][Full Text] [Related]
31. [Risk factors in the development of bleeding peptic ulcer]. Stevanović D; Ivanisević V Med Pregl; 1999; 52(9-10):379-84. PubMed ID: 10624388 [TBL] [Abstract][Full Text] [Related]
32. [Role of non-steroidal anti-inflammatory drugs on upper gastrointestinal bleeding]. Sułek M; Steinbrich-Zoller M; Dudek A; Jancelewicz J; Niedziałek D Pol Merkur Lekarski; 2005 Nov; 19(113):642-5. PubMed ID: 16498802 [TBL] [Abstract][Full Text] [Related]
33. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs. Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591 [TBL] [Abstract][Full Text] [Related]
34. Peptic ulcer disease and the nonsteroidal anti-inflammatory drugs. Peoples JB Am Surg; 1985 Jun; 51(6):358-62. PubMed ID: 3994179 [TBL] [Abstract][Full Text] [Related]
35. Association of cocaine and methamphetamine use with giant gastroduodenal ulcers. Pecha RE; Prindiville T; Pecha BS; Camp R; Carroll M; Trudeau W Am J Gastroenterol; 1996 Dec; 91(12):2523-7. PubMed ID: 8946979 [TBL] [Abstract][Full Text] [Related]
36. Prevalence of Helicobacter pylori in peptic ulcer disease in a Singapore hospital. Vu C; Ng YY Singapore Med J; 2000 Oct; 41(10):478-81. PubMed ID: 11281437 [TBL] [Abstract][Full Text] [Related]
37. Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor. Goldstein JL; Silverstein FE; Agrawal NM; Hubbard RC; Kaiser J; Maurath CJ; Verburg KM; Geis GS Am J Gastroenterol; 2000 Jul; 95(7):1681-90. PubMed ID: 10925968 [TBL] [Abstract][Full Text] [Related]
38. [Gastroduodenal complications associated with non-steroidal anti-inflammatory drugs in Slovak Republic: results of one-year prospective study]. Rybár I; Hlísta M; Masaryk P; Rovenský J; Hyrdel R; Kriska M Vnitr Lek; 2006; 52(7-8):673-6. PubMed ID: 16967607 [TBL] [Abstract][Full Text] [Related]
39. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study. Vonkeman HE; Fernandes RW; van der Palen J; van Roon EN; van de Laar MA Arthritis Res Ther; 2007; 9(3):R52. PubMed ID: 17521422 [TBL] [Abstract][Full Text] [Related]
40. Nonsteroidal antiinflammatory drug-induced mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori. Rybár I; Masaryk P; Mateicka F; Kopecký S; Rovenský J Int J Clin Pharmacol Res; 2001; 21(3-4):119-25. PubMed ID: 12067141 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]